\n\n\n \n \n\n \n \n \n \n\n\n \n\n \n\n Nov 18, 2009 4:01 PM EST
\n\n \n Genentech and Biogen Idec Receive a Complete Response from the FDA for Rituxan for Chronic Lymphocytic Leukemia - Business Wire\n \n \n | \n\n \n\n \n\n \n\n Nov 12, 2009 9:48 AM EST
\n\n \n PanGenetics Announces Acquisition by Abbott of PG110 anti-NGF Antibody to Treat Chronic Pain - Business Wire\n \n \n | \n\n \n\n \n\n \n\n Nov 11, 2009 6:41 AM EST
\n\n \n Complimentary Sector & Company Analysis on ABAT, EXEL, LBTYA, BEBE, INTU and BIIB From TheFortuneFinancial.com - Marketwire\n \n \n | \n\n \n\n \n\n \n\n Nov 10, 2009 5:00 PM EST
\n\n \n Zacks Industry Outlook Highlights: Alcon, Novartis, Gilead Sciences, Biogen Idec and Acorda Therapeutics - Business Wire\n \n \n | \n\n \n\n \n\n \n\n Nov 10, 2009 3:55 PM EST
\n\n \n Biogen Idec to Present at the Lazard Capital Markets 6th Annual Healthcare Conference - Business Wire\n \n \n | \n\n \n\n \n\n \n\n Nov 09, 2009 5:35 PM EST
\n\n \n Biogen Idec to Present at the 2009 Annual Credit Suisse Healthcare Conference - Business Wire\n \n \n | \n\n \n\n \n\n \n\n Nov 09, 2009 5:35 PM EST
\n\n \n CORRECTING and REPLACING Biogen Idec to Present at the 2009 Annual Credit Suisse Healthcare Conference - Business Wire\n \n \n | \n\n \n\n \n | \n
\n\n
\n\n");